Press release
Researchers at the University of Dundee have made a discovery they believe has the potential to put the brakes on the ‘runaway train’ that is Parkinson’s disease.
Press release
Researchers at the University of Dundee have made a discovery they believe has the potential to put the brakes on the ‘runaway train’ that is Parkinson’s disease.
Press release
Researchers at the University of Dundee have discovered an enzyme they believe could be key to preventing Group A Streptococcus infections that cause more than 500,000 deaths worldwide each year
Feature
Parkinson’s is the fastest growing neurological condition in the world and at present, there is no cure
Press release
An entrepreneurial scientist from the University of Dundee has proven his business concept is more than skin deep after winning one of the country’s top enterprise awards
Feature
The Dundee Parkinson’s Campaign is undoubtedly ambitious, but the University has never shied away from a challenge, particularly when it comes to world-leading research
Press release
The University of Dundee Drug Discovery Unit is delighted to announce it has licensed assets to Corbin Therapeutics to develop possible new treatments for neuroinflammation-based disorders, including multiple sclerosis (MS).
Press release
Green-fingered families could become plant scientists and explore the power of plants this weekend as the University of Dundee and the James Hutton Institute host a free celebration of flowers and fauna at the University’s Botanic Garden
Press release
Exscientia, a world leader in artificial intelligence (“AI”) driven drug discovery and a spinout company of the University of Dundee announced today that it has entered a three-year AI drug discovery partnership with leading biopharma company Celgene
News
The School of Life Sciences has been awarded a prestigious Gold Watermark for its work in bringing world-class science to the wider community.
News
Evotec invests in Exscientia to advance AI-driven drug discovery
News
A new diagnostic test developed from research at the Universities of Dundee and Cambridge has been launched with the aim of helping eliminate the disease known as African sleeping sickness.
News
Pre-clinical collaboration focused on up to 10 targets nominated by GSK